Cigna Corporation (NASDAQ:CI) Files An 8-K Results of Operations and Financial Condition

Item 7.01 Regulation FD Disclosure.

Cigna Corporation (“Cigna”) officials expect to participate in
meetings and events with investors and analysts on January 10 and
11, 2017 at the J.P. Morgan Healthcare Conference, including a
presentation by David M. Cordani, Cigna’s President and Chief
Executive Officer. During these meetings, Cigna officials expect
to provide projections for full year 2017 total medical customer
growth. Cigna expects growth of 300,000 to 500,000 total medical
customers over 2016, driven by growth in each Commercial employer
market segment (National Accounts, Middle Market, Select, and
International), an increase of approximately 100,000 customers in
the U.S. Individual business, and a decline of approximately
50,000 Medicare Advantage customers.

In addition, Cigna officials expect to disclose preliminary
expectations that shareholders’ net income for full year 2016 is
projected to be in the range of $1.870 billion to $1.940 billion
and reaffirm projected full year 2016 consolidated adjusted
income from operations, which remains in the range of $2.025
billion to $2.095 billion, as described in the table below.

Because the financial statements for the year ended December 31,
2016 have not yet been completed and will be subject to closing
adjustments and audit procedures, the estimates provided herein
are subject to change and actual results may differ materially
from these estimates.

Cigna discussed its full year 2016 outlook in its press release
dated November 3, 2016 and during the related investor conference
call. The press release and the conference call transcript are
available under Quarterly Reports and SEC Filings in the Investor
Relations section of the Company’s website located at
www.cigna.com/aboutcigna/investors.

Adjusted income (loss) from operations is defined as
shareholders’ net income (loss) excluding the following
after-tax adjustments: net realized investment results, net
amortization of other acquired intangible assets and special
items. Adjusted income (loss) from operations is a measure of
profitability used by Cigna’s management because it presents the
underlying results of operations of Cigna’s businesses and
permits analysis of trends in underlying revenue, expenses and
shareholders’ net income. This consolidated measure is not
determined in accordance with accounting principles generally
accepted in the United States of America (“GAAP”) and should
not be viewed as a substitute for the most directly comparable
GAAP measure, shareholders’ net income.

Cigna’s presentation is expected to begin at approximately 9:30
a.m. PST on January 11, 2017. Investors, analysts, and the
general public are invited to listen to the presentation free
over the Internet via webcast by visiting http://www.cigna.com
and clicking on About Cigna, then Investor Relations, then the
Investor Events link. To listen to this presentation live on the
Internet, visit http://www.cigna.com at least 15 minutes prior to
the presentation (to download and install any necessary audio
software).

This information shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the
Exchange Act whether made before or after the date of this
report, except as shall be expressly set forth by specific
reference in such a filing.

CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS
OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This Current Report on Form 8-K (the “Report”), and oral
statements made with respect to information contained in this
Report, may contain forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are based on Cigna’s current
expectations and projections about future trends, events and
uncertainties. These statements are not historical facts.
Forward-looking statements may include, among others, statements
relating to our projected full year 2016 shareholders’ net
income and consolidated adjusted income from operations and
projected 2017 total medical customer growth, each as reflected
in this Report, as well as statements made in our press release
dated November 3, 2016 and related investor conference call
concerning our projected adjusted income (loss) from operations
outlook for 2016, on both a consolidated and segment basis and
projected total revenue growth and global medical customer
growth, each over year end 2015; projected medical care and
operating expense ratios and medical cost trends; future
financial or operating performance, including our ability to
deliver personalized and innovative solutions for our customers
and clients and future growth, business strategy, strategic or
operational initiatives; economic, regulatory or competitive
environments, particularly with respect to the pace and extent of
change in these areas; financing or capital deployment plans and
amounts available for future deployment; our prospects for growth
in the coming years; statements regarding the proposed merger
between Cigna and Anthem; statements regarding the timing of
resolution of the issues raised by CMS; and other statements
regarding Cigna’s and Anthem’s future beliefs, expectations,
plans intentions, financial condition or performance. You may
identify forward-looking statements by the use of words such as
“believe”, “expect”, “plan”, “intend”, “anticipate”,
“estimate”, “predict”, “potential”, “may”, “should”,
“will” or other words or expressions of similar meaning,
although not all forward-looking statements contain such terms.

Forward-looking statements are subject to risks and
uncertainties, both known and unknown, that could cause actual
results to differ materially from those expressed or implied in
forward-looking statements. Such risks and uncertainties include,
but are not limited to: our ability to achieve our financial,
strategic and operational plans or initiatives; our ability to
predict and manage medical costs and price effectively and
develop and maintain good relationships with physicians,
hospitals and other health care providers; the impact of
modifications to our operations and processes, including those in
our disability business; our ability to identify potential
strategic acquisitions or transactions and realize the expected
benefits of such transactions; the substantial level of
government regulation over our business and the potential effects
of new laws or regulations, or changes in existing laws or
regulations; the outcome of litigation, regulatory audits,
including the CMS review and sanctions, investigations and
actions and/or guaranty fund assessments; uncertainties
surrounding participation in government-sponsored programs such
as Medicare; the effectiveness and security of our information
technology and other business systems; and unfavorable industry,
economic or political conditions, including foreign currency
movements; the timing and likelihood of completion of the
proposed merger, including the timing, receipt and terms and
conditions of any required governmental and regulatory approvals
for the proposed merger that could reduce anticipated benefits or
cause the parties to abandon the transaction; the possibility
that the expected synergies and value creation from the proposed
merger will not be realized or will not be realized within the
expected time period; the risk that the businesses of Cigna and
Anthem will not be integrated successfully; disruption from the
proposed merger making it more difficult to maintain business and
operational relationships; the risk that unexpected costs will be
incurred; the possibility that the proposed merger does not
close, including due to the failure to satisfy the closing
conditions; the risk that financing for the proposed merger may
not be available on favorable terms, as well as more specific
risks and uncertainties discussed in our most recent report on
Form 10-K and subsequent reports on Forms 10-Q and 8-K available
on the Investor Relations section of www.cigna.com as well as on
Anthem’s most recent report on Form 10-K and subsequent reports
on Forms 10-Q and 8-K available on the Investor Relations section
of www.antheminc.com. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made, are not guarantees of future performance or results,
and are subject to risks, uncertainties and assumptions that are
difficult to predict or quantify. Cigna undertakes no obligation
to update or revise any forward-looking statement, whether as a
result of new information, future events or otherwise, except as
may be required by law.